The Erythropoietin Receptor Gene Mutation Analysis Test is a specialized diagnostic procedure designed to identify mutations in the gene that encodes the erythropoietin receptor (EPOR). This receptor plays a crucial role in the regulation of red blood cell production in the body. Mutations in the EPOR gene can lead to various hematological disorders, including erythrocytosis, which is characterized by an abnormal increase in the number of red blood cells, potentially leading to complications such as blood clots, stroke, and heart attack.
Conducted at DNA Labs UAE, this test offers a comprehensive analysis to detect any genetic alterations in the erythropoietin receptor gene, aiding in the accurate diagnosis and management of conditions associated with EPOR mutations. The test is particularly valuable for individuals presenting symptoms of erythrocytosis, those with a family history of hematological disorders, or as part of a broader genetic investigation.
Priced at 1800 AED, the Erythropoietin Receptor Gene Mutation Analysis Test is accessible for patients seeking advanced genetic testing services in the UAE. The cost reflects the sophisticated technology and expertise required to perform this intricate analysis. By choosing DNA Labs UAE, patients can expect precise results, which are crucial for the development of targeted treatment strategies, ultimately improving patient outcomes in managing conditions related to EPOR gene mutations.
The FGFR1 Solid Tumor Test is a specialized diagnostic examination designed to detect alterations in the Fibroblast Growth Factor Receptor 1 (FGFR1) gene, which can be indicative of various solid tumors. This test is particularly significant in the realm of personalized medicine, as FGFR1 gene mutations or amplifications are associated with a range of cancers, including breast, lung, and bladder cancers, among others. Identifying such genetic abnormalities can guide oncologists in tailoring targeted therapies for patients, enhancing treatment efficacy and potentially improving outcomes.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test utilizes advanced genomic technologies to analyze tumor DNA for FGFR1 abnormalities. The cost of the FGFR1 Solid Tumor Test is set at 1800 AED, reflecting the comprehensive analysis and detailed reporting provided. By opting for this test, patients and healthcare providers can access critical genetic information that may unlock personalized treatment pathways, contributing to more effective cancer care strategies.
The FOXO1 Break Apart FISH (Fluorescence In Situ Hybridization) Alveolar Rhabdomyosarcoma Diagnostic Test is a highly specialized laboratory test designed to detect genetic abnormalities associated with alveolar rhabdomyosarcoma (ARMS), a type of cancer that primarily affects muscle tissue. This test focuses on identifying the disruption or "break apart" of the FOXO1 gene, which is a hallmark of ARMS. The presence of such genetic rearrangements can help in confirming a diagnosis of alveolar rhabdomyosarcoma, thereby enabling healthcare providers to tailor treatment plans more effectively.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test employs the FISH technique to visualize and map the genetic material within a patient's cells. This method allows for the precise detection of genetic translocations involving the FOXO1 gene, which are critical for diagnosing ARMS. The cost of the FOXO1 Break Apart FISH Alveolar Rhabdomyosarcoma Diagnostic Test is 1800 AED, reflecting the advanced technology and expertise required to conduct this specialized diagnostic procedure.
By providing a clear genetic profile of the tumor, this test plays a crucial role in the management of alveolar rhabdomyosarcoma, guiding decisions regarding the most appropriate and effective treatment strategies.
The "Chromosomes 13, 18, 21, X, and Y Test" is a specialized genetic screening conducted at DNA Labs UAE, designed to detect chromosomal abnormalities related to these specific chromosomes. This test plays a crucial role in diagnosing conditions such as Down syndrome (Trisomy 21), Patau syndrome (Trisomy 13), Edwards syndrome (Trisomy 18), and various sex chromosome anomalies that can impact an individual's development and health. The process involves analyzing a sample of blood or amniotic fluid to identify any extra or missing chromosomes or abnormalities in the structure of chromosomes 13, 18, 21, X, and Y. This test is significant for expectant parents or individuals seeking insight into their genetic health or reproductive risks. The cost for this comprehensive chromosomal test at DNA Labs UAE is 1950 AED, offering valuable information for early intervention and management of potential genetic conditions.
The "IHC Extended Panel >10 Markers" test, available at DNA Labs UAE, is a comprehensive immunohistochemistry (IHC) analysis designed to examine more than 10 specific markers in a tissue sample. This advanced diagnostic tool is crucial for identifying the presence and expression levels of various proteins that can provide valuable insights into the nature of diseases, particularly in the context of cancer. By targeting a wide range of markers, this extended panel enhances the precision of diagnosis, prognosis, and helps in determining the most effective treatment strategies.
The cost of the "IHC Extended Panel >10 Markers" test at DNA Labs UAE is set at 1950 AED. This investment in health diagnosis enables healthcare professionals to tailor treatment plans more accurately to the individual's condition, potentially leading to better outcomes. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring high-quality and reliable test results. This test is an invaluable resource for patients and doctors alike, providing critical information that supports informed decision-making in complex clinical scenarios.
The "IHC Up to 5 Markers Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to analyze up to five immunohistochemistry (IHC) markers. This test plays a crucial role in the field of pathology and oncology, as it helps in the detailed examination of tissues to identify specific cellular components, proteins, and markers that are pivotal in diagnosing various diseases, including different types of cancers. By utilizing antibodies to detect these markers in tissue samples, the test provides valuable information on the presence, absence, or quantity of these markers, aiding in the determination of the disease type and its progression. The cost of the IHC Up to 5 Markers Test at DNA Labs UAE is set at 1950 AED, reflecting the sophisticated technology and expertise required to conduct this intricate analysis. This test is a vital tool for healthcare professionals in making accurate diagnoses and developing effective treatment plans for patients.
The "Large Biopsy 8 Test" is a comprehensive diagnostic procedure offered by DNA Labs UAE, designed to analyze large biopsy samples for a wide array of medical conditions. This advanced test plays a critical role in the detection, diagnosis, and management of diseases by examining tissue samples under a microscopic lens to identify cellular abnormalities, infections, or cancerous developments. Priced at 1950 AED, the test offers a cost-effective solution for patients seeking in-depth analysis and insights into their health conditions. DNA Labs UAE utilizes state-of-the-art technology and expertise to ensure accurate, reliable, and timely results, aiding healthcare professionals in devising effective treatment plans.
The "Periodontal Multiplex Detection and Differentiation Test" is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to identify and differentiate between four major bacteria associated with periodontal diseases: Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, and Fusobacterium nucleatum. This qualitative RNA detection test utilizes advanced molecular techniques to accurately identify the presence of these pathogens in a patient's sample, enabling healthcare professionals to tailor more effective treatment strategies for periodontal conditions.
Periodontal diseases, which affect the tissues supporting the teeth, can lead to severe dental issues and even tooth loss if not properly managed. The bacteria targeted by this test are known to be key contributors to the development and progression of periodontal disease, making their identification crucial for effective management and treatment.
The test is priced at 1950 AED and is conducted at DNA Labs UAE, a leading facility known for its state-of-the-art diagnostic services. By providing precise and timely detection of these periodontal pathogens, the test plays a vital role in the early intervention and management of periodontal diseases, ultimately contributing to better oral health outcomes for patients.
The "Periodontal Multiplex Detection and Differentiation Porphyromonas gulae, Treponema denticola, Tannerella forsythia, and Fusobacterium nucleatum RNA Detection Qualitative Test" is a specialized diagnostic procedure conducted at DNA Labs UAE. Priced at 2210 AED, this test is designed to accurately identify and differentiate between the RNA of four major bacteria known to cause periodontal disease: Porphyromonas gulae, Treponema denticola, Tannerella forsythia, and Fusobacterium nucleatum. Utilizing advanced molecular techniques, this qualitative test enables precise detection of these pathogens, offering crucial insights for the effective management and treatment of periodontal conditions. The test's multiplex approach not only ensures a comprehensive analysis but also aids in the early diagnosis of periodontal diseases, facilitating targeted interventions and improved patient outcomes.
This test is a sophisticated diagnostic tool designed to identify and differentiate between the RNA of four key bacteria known to cause periodontal disease: Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, and Tannerella forsythia. Utilizing advanced RNA detection techniques, this qualitative test is capable of pinpointing the specific bacteria present in the oral cavity, thereby enabling healthcare professionals to tailor more effective treatment strategies for periodontal disease.
Conducted at DNA Labs UAE, a leading facility in genetic and microbiological testing, this test offers a rapid and accurate assessment of the bacterial composition in periodontal pockets. With a cost of 2210 AED, it represents a significant investment in oral health, providing critical insights that can guide the management of periodontal diseases, from prevention through to advanced treatment modalities. The utilization of this test underscores the importance of precision medicine in dentistry, offering a personalized approach to periodontal care based on the specific pathogens involved.
